Invesco Funds - Invesco Global Health Care Innovation Fund A-Annual Distribution Shares USD
Equity fund
1 year
USA
Largest region
Medium
Risk
Annual costs
Morningstar
No
Sustainability
Development
Last 5 years
( ann.)
Details
- The Fund aims to achieve long-term capital growth. The Fund seeks to achieve its objective by investing primarily in equity and equity related securities of innovative healthcare companies throughout the world. For the purposes of the Fund, healthcare companies include (but are not limited to) companies in the sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies. The Investment Manager seeks to invest in companies that have the potential to materially improve the quality of care, access to care or cost of care through their innovative approach to products and services, use of technology, processes and business models, or management.
Investment horizon
- Invesco Funds - Invesco Global Health Care Innovation Fund A-Annual Distribution Shares USD is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.
Characteristics
- Minimum amount
- Sharpe 3 years
- NAV/Price
16 Dec 2025
- Margin rate
- Start date06 Sept 2018
- ISINLU1775982595
Risk
- Medium (4 of 7)
Morningstar rating
- The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.
Sustainability
- SustainabilityNo
Annual cost
- Ongoing costs
Includes management fees of 1,50 %
- Platform fee
- Kickback fee
- Annual running costs
Other costs
- Performance-based fee
- Transaction costs
Costs for any currency exchanges are not included.
Allocation
- Stocks 99%Interest 1%
Portfolio
Shows the fund's largest investments.
- Eli Lilly and Co9.7%
- Boston Scientific Corp7.6%
- Cencora Inc4.8%
- AbbVie Inc4.7%
- AstraZeneca PLC ADR4.1%
- argenx SE ADR3.7%
- Gilead Sciences Inc3.2%
- McKesson Corp3.2%
- Tenet Healthcare Corp2.4%
- Welltower Inc2.4%